161. Familial benign chronic pemphigus Disease details / Clinical trials / Drug dev / DR info /

(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime   
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;
Botulism Toxin Treatment   
   University Hospital, Toulouse
      2015   Phase 1   NCT02782702   -
Celecoxib   
   Juntendo university gradurate school of medicine
      2013   -   JPRN-UMIN000010191   Japan;
Doxycycline   
   Gangnam Severance Hospital
      2020   -   NCT05007223   Korea, Republic of;
LX3305 250 mg capsule   
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;
None   
   Dermecular Therapeutics, Inc.
      2018   Phase 1;Phase 2   EUCTR2018-000373-80-FR   France;